LOGIN
Adjuvant midazolam provides longer duration of sensory block in opium abusers
May 2013
Adjuvant midazolam provides longer duration of sensory block in opium abusers
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
The effect of adjuvant midazolam compared with fentanyl on the duration of spinal anesthesia with 0.5% bupivacaine in opium abusers
Korean J Anesthesiol. 2012 Dec;63(6):521-6. doi: 10.4097/kjae.2012.63.6.521. Epub 2012 Dec 14Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
90 opium abuser patients undergoing lower limb orthopedic surgery were randomized in order to determine which adjuvant is the most effective in providing a spinal block. Patients received 15 mg plain bupivacaine, 15 mg bupivacaine plus 25 mcg fentanyl, or 15 mg bupivacaine plus 1 mg midazolam. When assessed after the first 24 hours, patients receiving bupivacaine with midazolam had the longest sen...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.